Browse 1 active roles at Genetix Biotherapeutics. Filter by category, skill, type, and more.
1,000 jobs found
No matching roles right now. Try clearing some filters.
Genetix Biotherapeutics, founded 2026, is a 133 Privately Held in the Biotechnology Research industry headquartered in Somerville, Massachusetts, US.
The team focuses on gene therapy, gene addition, sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy.
Genetix Biotherapeutics, headquartered in Somerville, Massachusetts, operates within the biotechnology research industry as a privately held, commercial-stage organization. Formerly known as bluebird bio, the firm focuses on delivering genetic therapies designed to treat severe rare diseases. The company currently offers three FDA-approved, first-in-class treatments for sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy. These one-time administered therapies target the underlying causes of these conditions, aiming to provide significant and lasting benefits to patients and their families.
Building on decades of scientific innovation and clinical data gathered from hundreds of treated individuals, Genetix Biotherapeutics is positioned to expand its ecosystem. The organization concentrates on commercial execution, scaling patient access, and improving the overall treatment experience for patients, families, and healthcare providers. This approach supports the goal of reaching thousands of currently untreated patients.
See more: Genetix Biotherapeutics company profile, Browse all companies.